Bio Green Med Solution, Inc.
BGMS · XNASCIK 1130166fmd_1BJ7KTPJAG3Z1VQGGEE0GWV6PKWholesale Trade · Wholesale-Durable Goods, NECTemplate: Standard
Coverage: Apr 01, 1997 to Sep 30, 2026, 79 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Operating income
- (8)
- Net income
- (3)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Operating income
- (1)
- Net income
- (0)
- Free cash flow
- (0)
Daily close · BGMSIEX trades only
Nov 09, 2026 to Nov 11, 2026 · 2 sessions0.80 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
Bio Green Med Solution, Inc. (BGMS) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $43,000 | -100% | 10-K 2026-03-30 · proof |
| Operating income | -$8.4 million | -$12 million | 10-K 2026-03-30 · proof | |
| Net income | -$3 million | -$11.2 million | 10-K 2026-03-30 · proof | |
| Cash from operating activities | -$4.8 million | -$8 million | 10-K 2026-03-30 · proof | |
| Total assets | $8.2 million | $4.1 million | +99.9% | 10-K 2026-03-30 · proof |
| Total liabilities | $1.3 million | $6.3 million | -78.6% | 10-K 2026-03-30 · proof |
| Cash and cash equivalents | $3.5 million | $3.1 million | +11.7% | 10-K 2026-03-30 · proof |
- What was Bio Green Med Solution, Inc. (BGMS)'s revenue in fiscal 2025?
- Bio Green Med Solution, Inc. (BGMS) reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $43,000 the year before (-100%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Bio Green Med Solution, Inc. (BGMS)'s operating income in fiscal 2025?
- Bio Green Med Solution, Inc. (BGMS) reported operating income of -$8.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Bio Green Med Solution, Inc. (BGMS)'s net income in fiscal 2025?
- Bio Green Med Solution, Inc. (BGMS) reported net income of -$3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$11.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Bio Green Med Solution, Inc. (BGMS)'s cash from operating activities in fiscal 2025?
- Bio Green Med Solution, Inc. (BGMS) reported cash from operating activities of -$4.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Bio Green Med Solution, Inc. (BGMS)'s total assets?
- As of Dec 31, 2025, Bio Green Med Solution, Inc. (BGMS) reported total assets of $8.2 million, against $4.1 million a year earlier (+99.9%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Bio Green Med Solution, Inc. (BGMS)'s total liabilities?
- As of Dec 31, 2025, Bio Green Med Solution, Inc. (BGMS) reported total liabilities of $1.3 million, against $6.3 million a year earlier (-78.6%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Bio Green Med Solution, Inc. (BGMS)'s cash and cash equivalents?
- As of Dec 31, 2025, Bio Green Med Solution, Inc. (BGMS) reported cash and cash equivalents of $3.5 million, against $3.1 million a year earlier (+11.7%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BGMS&period_type=annual&limit=5"Information only, not investment advice.